Grogan M - Search Results

1

Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis.

Fine NM, Arruda-Olson AM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kyle RA, Swiecicki PL, Scott CG, Grogan M. Fine NM, et al. Among authors: grogan m. Am J Cardiol. 2014 May 15;113(10):1723-7. doi: 10.1016/j.amjcard.2014.02.030. Epub 2014 Mar 2. Am J Cardiol. 2014. PMID: 24698461

2

Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy.

Grogan M, Smith HC, Gersh BJ, Wood DL. Grogan M, et al. Am J Cardiol. 1992 Jun 15;69(19):1570-3. doi: 10.1016/0002-9149(92)90705-4. Am J Cardiol. 1992. PMID: 1598871

3

Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy.

Grogan M, Redfield MM, Bailey KR, Reeder GS, Gersh BJ, Edwards WD, Rodeheffer RJ. Grogan M, et al. J Am Coll Cardiol. 1995 Jul;26(1):80-4. doi: 10.1016/0735-1097(95)00148-s. J Am Coll Cardiol. 1995. PMID: 7797779 Free article.

4

Presence of atrial natriuretic factor in ventricular tissue in tachycardia-induced cardiomyopathy.

Lloyd MA, Grogan M, Sandberg SM, Smith HC, Gersh BJ, Edwards WD, Edwards BS. Lloyd MA, et al. Among authors: grogan m. Am J Cardiol. 1994 May 15;73(13):984-6. doi: 10.1016/0002-9149(94)90150-3. Am J Cardiol. 1994. PMID: 8184864 No abstract available.

5

Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy.

Gertz MA, Grogan M, Kyle RA, Tajik AJ. Gertz MA, et al. Among authors: grogan m. Am J Cardiol. 1997 Jul 1;80(1):93-5. Am J Cardiol. 1997. PMID: 9205031

6

Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement.

Grogan M, Gertz MA, Kyle RA, Tajik AJ. Grogan M, et al. Am J Cardiol. 2000 Mar 1;85(5):664-5, A11. doi: 10.1016/s0002-9149(99)00832-2. Am J Cardiol. 2000. PMID: 11078288

7

Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.

Murtagh B, Hammill SC, Gertz MA, Kyle RA, Tajik AJ, Grogan M. Murtagh B, et al. Among authors: grogan m. Am J Cardiol. 2005 Feb 15;95(4):535-7. doi: 10.1016/j.amjcard.2004.10.028. Am J Cardiol. 2005. PMID: 15695149

8

Primary cardiac amyloidosis with 20-year survival.

Fealey ME, Edwards WD, Grogan M, Dispenzieri A. Fealey ME, et al. Among authors: grogan m. Cardiovasc Pathol. 2006 Nov-Dec;15(6):331-5. doi: 10.1016/j.carpath.2006.06.002. Cardiovasc Pathol. 2006. PMID: 17113011

9

Intracardiac thrombosis and embolism in patients with cardiac amyloidosis.

Feng D, Edwards WD, Oh JK, Chandrasekaran K, Grogan M, Martinez MW, Syed IS, Hughes DA, Lust JA, Jaffe AS, Gertz MA, Klarich KW. Feng D, et al. Among authors: grogan m. Circulation. 2007 Nov 20;116(21):2420-6. doi: 10.1161/CIRCULATIONAHA.107.697763. Epub 2007 Nov 5. Circulation. 2007. PMID: 17984380

10

Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis.

Feng D, Syed IS, Martinez M, Oh JK, Jaffe AS, Grogan M, Edwards WD, Gertz MA, Klarich KW. Feng D, et al. Among authors: grogan m. Circulation. 2009 May 12;119(18):2490-7. doi: 10.1161/CIRCULATIONAHA.108.785014. Epub 2009 May 4. Circulation. 2009. PMID: 19414641

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters